Sehhoon Park

Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer

Sehhoon Park, Chan‐Young Ock, Hyojin Kim et al. · Journal of Clinical Oncology · 2022 · 282 citations · Full text

Medicine, Immunology, Oncology +17

Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Rearranged or Translocated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

Sehhoon Park, Tae Min Kim, Ji‐Youn Han et al. · Journal of Clinical Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

Characteristics and Outcome of ROS1-Positive Non–Small Cell Lung Cancer Patients in Routine Clinical Practice

Sehhoon Park, Beung‐Chul Ahn, Sung Won Lim et al. · Journal of Thoracic Oncology · 2018 · 108 citations · Full text

Medicine, Oncology, Pathology +6

Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status

Jiyun Lee, Yoon‐La Choi, Joungho Han et al. · Journal of Thoracic Oncology · 2020 · 90 citations

Medicine, Oncology, Pharmacotherapy +13

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Sehhoon Park, Steve Olsen, Bo Mi Ku et al. · Cancer · 2021 · 74 citations · Full text

Medicine, Molecular Medicine, Oncology +17